Alector (ALEC) EBIT (2018 - 2026)
Alector's (ALEC) quarterly EBIT came in at -$24.4 million in Q2 2026, up 28.55% year-over-year from -$19.0 million in Q2 2025, and up 2.11% quarter-over-quarter from -$24.9 million in Q1 2026.
Analysis
Alector (ALEC) EBIT (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported EBIT for 9 consecutive years, with -$24.4 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBIT rose 28.55% year-over-year to -$24.4 million in Q2 2026; TTM through Jun 2026 was -$126.5 million, a 5.97% increase from a year earlier, with the FY2025 full-year figure at -$156.0 million, down 7.59% from the prior year.
- EBIT was -$24.4 million for Q2 2026 at Alector, up from -$24.9 million in the prior quarter.
- Over five years, EBIT peaked at $9.5 million in Q2 2022 and troughed at -$55.4 million in Q4 2022.
- A 5-year average of -$35.5 million and a median of -$43.9 million in 2022 frame the typical range for EBIT.
- Across the five-year window, EBIT jumped 117.13% in 2022 and plunged 1170.72% in 2024, its largest moves.
- Over 5 years, EBIT stood at -$55.4 million in 2022, then increased by 14.4% to -$47.5 million in 2023, then surged by 84.72% to -$7.2 million in 2024, then tumbled by 445.81% to -$39.6 million in 2025, then soared by 38.35% to -$24.4 million in 2026.
- The last three EBIT figures came in at -$24.4 million (Q2 2026), -$24.9 million (Q1 2026), and -$39.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 3.51 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | -10.39 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 1.25 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 1.29 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 493.00 Mn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | -815.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 231.44 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | -644.50 Mn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | -1.55 Mn |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | -24.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -24.39 Mn |
| Mar 31, 2026 | -24.92 Mn |
| Dec 31, 2025 | -39.57 Mn |
| Sep 30, 2025 | -37.61 Mn |
| Jun 30, 2025 | -34.14 Mn |
| Mar 31, 2025 | -44.70 Mn |
| Dec 31, 2024 | -7.25 Mn |
| Sep 30, 2024 | -48.43 Mn |
| Jun 30, 2024 | -45.61 Mn |
| Mar 31, 2024 | -43.71 Mn |
| Dec 31, 2023 | -47.45 Mn |
| Sep 30, 2023 | -50.58 Mn |
| Jun 30, 2023 | -3.59 Mn |
| Mar 31, 2023 | -50.12 Mn |
| Dec 31, 2022 | -55.44 Mn |
| Sep 30, 2022 | -47.75 Mn |
| Jun 30, 2022 | 9.48 Mn |
| Mar 31, 2022 | -44.12 Mn |
| Dec 31, 2021 | -55.73 Mn |
| Sep 30, 2021 | 126.33 Mn |